LOS ANGELES TIMES AND PUBLISHERS WEEKLY BESTSELLER • The powerful memoir of a young doctor and former college athlete diagnosed with a rare disease who spearheaded the search for a cure—and became a champion for a new approach to medical research. “A wonderful and moving chronicle of a doctor’s relentless pursuit, this book serves both patients and physicians in demystifying the science that lies behind medicine.”—Siddhartha Mukherjee, New York Times bestselling author of The Emperor of All Maladies and The Gene David Fajgenbaum, a former Georgetown quarterback, was nicknamed the Beast in medical school, where he was also known for his unmatched mental stamina. But things changed dramatically when he began suffering from inexplicable fatigue. In a matter of weeks, his organs were failing and he was read his last rites. Doctors were baffled by his condition, which they had yet to even diagnose. Floating in and out of consciousness, Fajgenbaum prayed for a second chance, the equivalent of a dramatic play to second the game into overtime. Miraculously, Fajgenbaum survived—only to endure repeated near-death relapses from what would eventually be identified as a form of Castleman disease, an extremely deadly and rare condition that acts like a cross between cancer and an autoimmune disorder. When he relapsed while on the only drug in development and realized that the medical community was unlikely to make progress in time to save his life, Fajgenbaum turned his desperate hope for a cure into concrete action: Between hospitalizations he studied his own charts and tested his own blood samples, looking for clues that could unlock a new treatment. With the help of family, friends, and mentors, he also reached out to other Castleman disease patients and physicians, and eventually came up with an ambitious plan to crowdsource the most promising research questions and recruit world-class researchers to tackle them. Instead of waiting for the scientific stars to align, he would attempt to align them himself. More than five years later and now married to his college sweetheart, Fajgenbaum has seen his hard work pay off: A treatment he identified has induced a tentative remission and his novel approach to collaborative scientific inquiry has become a blueprint for advancing rare disease research. His incredible story demonstrates the potency of hope, and what can happen when the forces of determination, love, family, faith, and serendipity collide. Praise for Chasing My Cure “A page-turning chronicle of living, nearly dying, and discovering what it really means to be invincible in hope.”—Angela Duckworth, #1 New York Times bestselling author of Grit “[A] remarkable memoir . . . Fajgenbaum writes lucidly and movingly . . . Fajgenbaum’s stirring account of his illness will inspire readers.”—Publishers Weekly

This is a story about a woman who, in the prime of her life, is diagnosed with an autoimmune disease called scleroderma. Doris, an upbeat and optimistic person, always looked on the bright side of life. That was about to change. A strange and mysterious disease was waiting to wreak havoc with her life. Nothing prepared her for this life-altering experience. Follow her courageous journey in dealing with an autoimmune disease and sifting through the maze of doctors and treatments.

LILLY STONE is a twelve year old medical prodigy who takes after her father and uses every opportunity to learn more about the world of medicine. Desperate to treat patients of her own, Lilly meets Andre on her way home from school and finds the opportunity she has longed for. Noticing that Andre had more than a minor injury, and a family who didn't trust doctors, Lilly works to bridge the gap and treat the boy while searching for the root cause of his poor health. Chasing A Cure - that's Lilly Stone's dream. GREG PLAYER IS A DEDICATED FAMILY PHYSICIAN IN WILMINGTON, NORTH CAROLINA. HAVING TREATED PATIENTS FOR OVER TWENTY YEARS, INCLUDING HUNDREDS OF DIABETIC PATIENTS, DR. PLAYER FINDS A PARTICULAR INTEREST IN THE DOCTOR AND PATIENT RELATIONSHIP. HE APPRECIATES THE SCIENCE AND ART OF MEDICINE, AND IS EXCITED TO SHARE THE MEDICAL WORLD WITH YOUNG READERS EVERYWHERE.

This book tells the story of the thousands of “health seekers” who journeyed to New Mexico from 1880 to 1940 seeking a cure for tuberculosis (TB), the leading killer in the United States at the time. By 1920 such health seekers represented an estimated 10 percent of New Mexico’s population. The influx of “lungers” as they were called—many of whom remained in New Mexico—would play a critical role in New Mexico’s struggle for statehood and in its growth. Nearly sixty sanatoriums were established around the state, laying the groundwork for the state’s current health-care system. Among New Mexico’s prominent lungers were artists Will Shuster and Carlos Vierra, who “came to heal and stayed to paint.” Bronson Cutting, brought to Santa Fe on a stretcher in 1910, became the influential publisher of the Santa Fe New Mexican and a powerful U.S Senator. Others included William R. Lovelace and Edgar T. Lassetter, founders of the Lovelace Clinic, as well as Senator Clinton P. Anderson, poet Alice Corbin Henderson, architect John Gaw Meem, aviator Katherine Stinson, and Dorothy McKibben, gatekeeper for the Manhattan Project. New Mexico’s most infamous outlaw, Billy the Kid, first arrived in New Mexico when his mother, Catherine Antrim, sought treatment in Silver City.

LOS ANGELES TIMES AND PUBLISHERS WEEKLY BESTSELLER • The powerful memoir of a young doctor and former college athlete diagnosed with a rare disease who spearheaded the search for a cure—and became a champion for a new approach to medical research. “A wonderful and moving chronicle of a doctor’s relentless pursuit, this book serves both patients and physicians in demystifying the science that lies behind medicine.”—Siddhartha Mukherjee, New York Times bestselling author of The Emperor of All Maladies and The Gene David Fajgenbaum, a former Georgetown quarterback, was nicknamed the Beast in medical school, where he was also known for his unmatched mental stamina. But things changed dramatically when he began suffering from inexplicable fatigue. In a matter of weeks, his organs were failing and he was read his last rites. Doctors were baffled by his condition, which they had yet to even diagnose. Floating in and out of consciousness, Fajgenbaum prayed for a second chance, the equivalent of a dramatic play to second the game into overtime. Miraculously, Fajgenbaum survived—only to endure repeated near-death relapses from what would eventually be identified as a form of Castleman disease, an extremely deadly and rare condition that acts like a cross between cancer and an autoimmune disorder. When he relapsed while on the only drug in development and realized that the medical community was unlikely to make progress in time to save his life, Fajgenbaum turned his desperate hope for a cure into concrete action: Between hospitalizations he studied his own charts and tested his own blood samples, looking for clues that could unlock a new treatment. With the help of family, friends, and mentors, he also reached out to other Castleman disease patients and physicians, and eventually came up with an ambitious plan to crowdsource the most promising research questions and recruit world-class researchers to tackle them. Instead of waiting for the scientific stars to align, he would attempt to align them himself. More than five years later and now married to his college sweetheart, Fajgenbaum has seen his hard work pay off: A treatment he identified has induced a tentative remission and his novel approach to collaborative scientific inquiry has become a blueprint for advancing rare disease research. His incredible story demonstrates the potency of hope, and what can happen when the forces of determination, love, family, faith, and serendipity collide. Praise for Chasing My Cure “A page-turning chronicle of living, nearly dying, and discovering what it really means to be invincible in hope.”—Angela Duckworth, #1 New York Times bestselling author of Grit “[A] remarkable memoir . . . Fajgenbaum writes lucidly and movingly . . . Fajgenbaum’s stirring account of his illness will inspire readers.”—Publishers Weekly

A compelling exploration of the mysteries of environmental toxicity and the community of “sensitives”—people with powerful, puzzling symptoms resulting from exposure to chemicals, fragrances, and cell phone signals, that have no effect on “normals.” They call themselves “sensitives.” Over fifty million Americans endure a mysterious environmental illness that renders them allergic to chemicals. Innocuous staples from deodorant to garbage bags wreak havoc on sensitives. For them, the enemy is modernity itself. No one is born with EI. It often starts with a single toxic exposure. Then the symptoms hit: extreme fatigue, brain fog, muscle aches, inability to tolerate certain foods. With over 85,000 chemicals in the environment, danger lurks around every corner. Largely ignored by the medical establishment and dismissed by family and friends, sensitives often resort to odd ersatz remedies, like lining their walls with aluminum foil or hanging mail on a clothesline for days so it can “off-gas” before they open it. Broudy encounters Brian Welsh, a prominent figure in the EI community, and quickly becomes fascinated by his plight. When Brian goes missing, Broudy travels with James, an eager, trusting sensitive to find Brian, investigate this disease, and delve into the intricate, ardent subculture that surrounds it. Their destination: Snowflake, the capital of the EI world. Located in eastern Arizona, it is a haven where sensitives can live openly without fear of toxins or the judgment of insensitive “normals.” While Broudy’s book is wry, pacey, and down-to-earth, it also dives deeply into compelling corners of medical and American history. He finds telling parallels between sensitives and their cultural forebears, from the Puritans to those refugees and dreamers who settled the West. Ousted from mainstream society, these latter-day exiles nonetheless shed bright light on the anxious, noxious world we all inhabit now.